Semaglutide paired with intensive behavioral therapy showed triple weight loss vs placebo

Subcutaneous semaglutide vs. placebo as adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity

A new study finds that 35% of people who took an obesity drug called Semaglutide lost more than 20% of their total body weight, after 68 weekly injections. About 75% lost more than 10% of their body weight. The average weight loss was 15.3 kg.